Vadadustat is an Orally Active HIF-PH Inhibitor for Anemia Research
Chronic kidney disease (CKD) develop anemia largely because of inappropriately low erythropoietin (EPO) production and insufficient iron available to erythroid precursors. EPO production is controlled by hypoxia‐inducible factor (HIF). HIF…